Duplication | NM_000059.4(BRCA2):c.918dup (p.Ser307Ter) | BRCA2 | Pathogenic | 13 | 32906532 | 32906533 | A | AT | reviewed by expert panel | ClinGen:CA026021 |
single nucleotide variant | NM_000059.4(BRCA2):c.91T>C (p.Trp31Arg) | BRCA2 | Likely pathogenic | 13 | 32893237 | 32893237 | T | C | criteria provided, single submitter | ClinGen:CA026029 |
single nucleotide variant | NM_000059.4(BRCA2):c.9207T>A (p.Cys3069Ter) | BRCA2 | Pathogenic | 13 | 32954233 | 32954233 | T | A | reviewed by expert panel | ClinGen:CA026033 |
Deletion | NM_000059.4(BRCA2):c.9227del (p.Gly3076fs) | BRCA2 | Pathogenic | 13 | 32954252 | 32954252 | AG | A | reviewed by expert panel | ClinGen:CA026039 |
single nucleotide variant | NM_000059.4(BRCA2):c.9247A>T (p.Lys3083Ter) | BRCA2 | Pathogenic | 13 | 32954273 | 32954273 | A | T | reviewed by expert panel | ClinGen:CA026049 |
Deletion | NM_000059.4(BRCA2):c.9253del (p.Thr3085fs) | BRCA2 | Pathogenic | 13 | 32954273 | 32954273 | GA | G | reviewed by expert panel | ClinGen:CA026054 |
single nucleotide variant | NM_000059.4(BRCA2):c.9256+1G>A | BRCA2 | Pathogenic/Likely pathogenic | 13 | 32954283 | 32954283 | G | A | criteria provided, multiple submitters, no conflicts | Breast Cancer Information Core (BIC) (BRCA2):9484+1&base_change=G to A,ClinGen:CA026057 |
single nucleotide variant | NM_000059.4(BRCA2):c.9256G>T (p.Gly3086Ter) | BRCA2 | Pathogenic | 13 | 32954282 | 32954282 | G | T | reviewed by expert panel | ClinGen:CA026059 |
single nucleotide variant | NM_000059.4(BRCA2):c.9257-1G>A | BRCA2 | Pathogenic/Likely pathogenic | 13 | 32968825 | 32968825 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA026064 |
single nucleotide variant | NM_000059.4(BRCA2):c.9257-1G>C | BRCA2 | Pathogenic | 13 | 32968825 | 32968825 | G | C | criteria provided, multiple submitters, no conflicts | Breast Cancer Information Core (BIC) (BRCA2):9485-1&base_change=G to C,ClinGen:CA026065 |